Sphingolipids and their metabolism in physiology and disease
Studies of bioactive lipids in general and sphingolipids in particular have intensified over the
past several years, revealing an unprecedented and unanticipated complexity of the …
past several years, revealing an unprecedented and unanticipated complexity of the …
GBA Variants and Parkinson Disease: Mechanisms and Treatments
L Smith, AHV Schapira - Cells, 2022 - mdpi.com
The GBA gene encodes for the lysosomal enzyme glucocerebrosidase (GCase), which
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
P Saftig, J Klumperman - Nature reviews Molecular cell biology, 2009 - nature.com
Lysosomes are the primary catabolic compartments of eukaryotic cells. They degrade
extracellular material that has been internalized by endocytosis and intracellular …
extracellular material that has been internalized by endocytosis and intracellular …
Glucocerebrosidase and its relevance to Parkinson disease
J Do, C McKinney, P Sharma, E Sidransky - Molecular neurodegeneration, 2019 - Springer
Mutations in GBA1, the gene encoding the lysosomal enzyme glucocerebrosidase, are
among the most common known genetic risk factors for the development of Parkinson …
among the most common known genetic risk factors for the development of Parkinson …
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
KS Hruska, ME LaMarca, CR Scott… - Human mutation, 2008 - Wiley Online Library
Gaucher disease (GD) is an autosomal recessive disorder caused by the deficiency of
glucocerebrosidase, a lysosomal enzyme that catalyses the hydrolysis of the glycolipid …
glucocerebrosidase, a lysosomal enzyme that catalyses the hydrolysis of the glycolipid …
The cell biology of lysosomal storage disorders
AH Futerman, G Van Meer - Nature reviews Molecular cell biology, 2004 - nature.com
Lysosomal storage disorders, of which more than 40 are known, are caused by the defective
activity of lysosomal proteins, which results in the intra-lysosomal accumulation of …
activity of lysosomal proteins, which results in the intra-lysosomal accumulation of …
The relationship between glucocerebrosidase mutations and Parkinson disease
A Migdalska‐Richards… - Journal of …, 2016 - Wiley Online Library
Parkinson disease (PD) is the second most common neurodegenerative disorder after
Alzheimer disease, whereas Gaucher disease (GD) is the most frequent lysosomal storage …
Alzheimer disease, whereas Gaucher disease (GD) is the most frequent lysosomal storage …
[HTML][HTML] β-Glucosidases
JRK Cairns, A Esen - Cellular and molecular life sciences: CMLS, 2010 - ncbi.nlm.nih.gov
Abstract β-Glucosidases (3.2. 1.21) are found in all domains of living organisms, where they
play essential roles in the removal of nonreducing terminal glucosyl residues from …
play essential roles in the removal of nonreducing terminal glucosyl residues from …
Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system
Y Shaaltiel, D Bartfeld, S Hashmueli… - Plant biotechnology …, 2007 - Wiley Online Library
Gaucher's disease, a lysosomal storage disorder caused by mutations in the gene encoding
glucocerebrosidase (GCD), is currently treated by enzyme replacement therapy using …
glucocerebrosidase (GCD), is currently treated by enzyme replacement therapy using …
Glycosphingolipids—nature, function, and pharmacological modulation
T Wennekes, RJ van den Berg, RG Boot… - Angewandte Chemie …, 2009 - Wiley Online Library
The discovery of the glycosphingolipids is generally attributed to Johan LW Thudichum, who
in 1884 published on the chemical composition of the brain. In his studies he isolated …
in 1884 published on the chemical composition of the brain. In his studies he isolated …